East Kent Wet Age-Related Macular Degeneration Service
What the buyer wrote
Background: NICE Technology Appraisals (TA) for the use of intravitreally injected medication have had a significant impact on the treatment of macular disease associated with the development of choroidal neovascularisation (CNV). These conditions are Wet Age-related Macular Degeneration (WAMD) and Myopic Degeneration with CNV (Myopia CNV). Not only have these previously untreatable or poorly responsive disease states now become amenable to treatment but they also now require lifelong monitoring. NICE have approved the use of both Ranibizumab and Aflibercept for treating WAMD and Ranibizumab for treating Myopia CNV Currently all treatment and monitoring of these 2 macular conditions is …
Details
- What the buyer calls it
- East Kent Wet Age-Related Macular Degeneration Service
- How they are buying
- Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 30 Sep 2015
- Work ends
- 30 Sep 2018
- Kind of work
- Mental health and wellbeing services
Who the buyer named
The Authority Project Manager was the named contact on this notice.